Clinical impact of Geistlich TauroSept® as catheter lock in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017231

Enrollment

Registered

2019-05-02

Start date

2019-05-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter related bloodstream infection (CRBSI) Katheterdysfuntion

Interventions

Group 1: Retrospective health-related data collection and analysis of hemodialysis patients, who have used Geistlich TauroSept® as catheter lock solution and were treated in the hospital Linth. Group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient are informed about the intention to use his/her pseudonymized health data for research; Hemodialysis patient using Geistlich TauroSept® as catheter lock, treated in the institution Spital Linth, Gasterstrasse 25, 8730 Uznach

Exclusion criteria

Exclusion criteria: Presence of a written or orally communicated and documented objection

Design outcomes

Primary

Measure	Time frame
Catheter-related blood stream infection rate	—

Secondary

Measure	Time frame
Catheter-associated parameters	—

Countries

Switzerland

Contacts

Public ContactMadlen Bach

Geistlich Pharma AG

madlen.bach@geistlich.ch+41 41 492 67 48

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026